Literature DB >> 24060597

Mitochondria: gatekeepers of response to chemotherapy.

Kristopher A Sarosiek1, Triona Ni Chonghaile, Anthony Letai.   

Abstract

Mitochondria are cellular organelles that regulate commitment to and execution of apoptosis. The intrinsic apoptotic pathway culminates in the permeabilization of the mitochondrial outer membrane and dismantling of the cell. Apoptosis of cancer cells is a favorable outcome when administering chemotherapeutic treatment, yet the basis for why some cancers are sensitive to chemotherapy whereas others are not has historically been poorly understood. In this review, we present recent work that has demonstrated the importance of mitochondrial apoptotic priming, or how close a cell is to the threshold of apoptosis, in determining whether a cell will undergo apoptosis after chemotherapy treatment. Differential levels of apoptotic priming in tumors create bona fide opportunities and challenges for effective use of targeted and cytotoxic chemotherapies.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  apoptosis; chemotherapeutic window; chemotherapy; mitochondrial apoptotic priming

Mesh:

Year:  2013        PMID: 24060597      PMCID: PMC3842421          DOI: 10.1016/j.tcb.2013.08.003

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  87 in total

1.  ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.

Authors:  Andrew J Souers; Joel D Leverson; Erwin R Boghaert; Scott L Ackler; Nathaniel D Catron; Jun Chen; Brian D Dayton; Hong Ding; Sari H Enschede; Wayne J Fairbrother; David C S Huang; Sarah G Hymowitz; Sha Jin; Seong Lin Khaw; Peter J Kovar; Lloyd T Lam; Jackie Lee; Heather L Maecker; Kennan C Marsh; Kylie D Mason; Michael J Mitten; Paul M Nimmer; Anatol Oleksijew; Chang H Park; Cheol-Min Park; Darren C Phillips; Andrew W Roberts; Deepak Sampath; John F Seymour; Morey L Smith; Gerard M Sullivan; Stephen K Tahir; Chris Tse; Michael D Wendt; Yu Xiao; John C Xue; Haichao Zhang; Rod A Humerickhouse; Saul H Rosenberg; Steven W Elmore
Journal:  Nat Med       Date:  2013-01-06       Impact factor: 53.440

2.  Direct and selective small-molecule activation of proapoptotic BAX.

Authors:  Evripidis Gavathiotis; Denis E Reyna; Joseph A Bellairs; Elizaveta S Leshchiner; Loren D Walensky
Journal:  Nat Chem Biol       Date:  2012-05-27       Impact factor: 15.040

Review 3.  The role of p53 in apoptosis.

Authors:  Joana D Amaral; Joana M Xavier; Clifford J Steer; Cecília M Rodrigues
Journal:  Discov Med       Date:  2010-02       Impact factor: 2.970

4.  CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma.

Authors:  Robert Marcus; Kevin Imrie; Andrew Belch; David Cunningham; Eduardo Flores; John Catalano; Philippe Solal-Celigny; Fritz Offner; Jan Walewski; Joäo Raposo; Andrew Jack; Paul Smith
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

5.  Novel chemo-sensitizing agent, ERW1227B, impairs cellular motility and enhances cell death in glioblastomas.

Authors:  Liya Yuan; Tracy C Holmes; R Edward Watts; Chaitan Khosla; Tom J Broekelmann; Robert Mecham; Hong Zheng; Enrique W Izaguirre; Keith M Rich
Journal:  J Neurooncol       Date:  2010-09-08       Impact factor: 4.130

6.  Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study.

Authors:  Jedd D Wolchok; Bart Neyns; Gerald Linette; Sylvie Negrier; Jose Lutzky; Luc Thomas; William Waterfield; Dirk Schadendorf; Michael Smylie; Troy Guthrie; Jean-Jacques Grob; Jason Chesney; Kevin Chin; Kun Chen; Axel Hoos; Steven J O'Day; Celeste Lebbé
Journal:  Lancet Oncol       Date:  2009-12-08       Impact factor: 41.316

7.  Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML.

Authors:  Thanh-Trang Vo; Jeremy Ryan; Ruben Carrasco; Donna Neuberg; Derrick J Rossi; Richard M Stone; Daniel J Deangelo; Mark G Frattini; Anthony Letai
Journal:  Cell       Date:  2012-10-12       Impact factor: 41.582

Review 8.  The role of tumour-stromal interactions in modifying drug response: challenges and opportunities.

Authors:  Douglas W McMillin; Joseph M Negri; Constantine S Mitsiades
Journal:  Nat Rev Drug Discov       Date:  2013-03       Impact factor: 84.694

9.  Identification of the molecular basis of doxorubicin-induced cardiotoxicity.

Authors:  Sui Zhang; Xiaobing Liu; Tasneem Bawa-Khalfe; Long-Sheng Lu; Yi Lisa Lyu; Leroy F Liu; Edward T H Yeh
Journal:  Nat Med       Date:  2012-10-28       Impact factor: 53.440

10.  BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations.

Authors:  Daniel B Costa; Balázs Halmos; Amit Kumar; Susan T Schumer; Mark S Huberman; Titus J Boggon; Daniel G Tenen; Susumu Kobayashi
Journal:  PLoS Med       Date:  2007-10       Impact factor: 11.069

View more
  70 in total

1.  BH3 Profiling: A Functional Assay to Measure Apoptotic Priming and Dependencies.

Authors:  Cameron Fraser; Jeremy Ryan; Kristopher Sarosiek
Journal:  Methods Mol Biol       Date:  2019

Review 2.  Mitochondrial cholesterol: mechanisms of import and effects on mitochondrial function.

Authors:  Laura A Martin; Barry E Kennedy; Barbara Karten
Journal:  J Bioenerg Biomembr       Date:  2014-11-26       Impact factor: 2.945

Review 3.  The Mitochondrion as an Emerging Therapeutic Target in Cancer.

Authors:  Katherine G Roth; Isa Mambetsariev; Prakash Kulkarni; Ravi Salgia
Journal:  Trends Mol Med       Date:  2019-07-18       Impact factor: 11.951

4.  Yap1 safeguards mouse embryonic stem cells from excessive apoptosis during differentiation.

Authors:  Lucy LeBlanc; Bum-Kyu Lee; Andy C Yu; Mijeong Kim; Aparna V Kambhampati; Shannon M Dupont; Davide Seruggia; Byoung U Ryu; Stuart H Orkin; Jonghwan Kim
Journal:  Elife       Date:  2018-12-18       Impact factor: 8.140

5.  Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer.

Authors:  Elizabeth H Stover; Maria B Baco; Ofir Cohen; Yvonne Y Li; Elizabeth L Christie; Mukta Bagul; Amy Goodale; Yenarae Lee; Sasha Pantel; Matthew G Rees; Guo Wei; Adam G Presser; Maya K Gelbard; Weiqun Zhang; Ioannis K Zervantonakis; Patrick D Bhola; Jeremy Ryan; Jennifer L Guerriero; Joan Montero; Felice J Liang; Andrew D Cherniack; Federica Piccioni; Ursula A Matulonis; David D L Bowtell; Kristopher A Sarosiek; Anthony Letai; Levi A Garraway; Cory M Johannessen; Matthew Meyerson
Journal:  Mol Cancer Res       Date:  2019-08-28       Impact factor: 5.852

Review 6.  Many players in BCL-2 family affairs.

Authors:  Tudor Moldoveanu; Ariele Viacava Follis; Richard W Kriwacki; Douglas R Green
Journal:  Trends Biochem Sci       Date:  2014-02-03       Impact factor: 13.807

Review 7.  Mitochondrial microRNA (MitomiRs) in cancer and complex mitochondrial diseases: current status and future perspectives.

Authors:  Paresh Kumar Purohit; Neeru Saini
Journal:  Cell Mol Life Sci       Date:  2020-10-21       Impact factor: 9.261

Review 8.  Radiation-Induced Cardiovascular Toxicity: Mechanisms, Prevention, and Treatment.

Authors:  Johan Spetz; Javid Moslehi; Kristopher Sarosiek
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-20

Review 9.  Restoration of mitochondria function as a target for cancer therapy.

Authors:  Tariq A Bhat; Sandeep Kumar; Ajay K Chaudhary; Neelu Yadav; Dhyan Chandra
Journal:  Drug Discov Today       Date:  2015-03-09       Impact factor: 7.851

10.  A caspase-independent way to kill cancer cells.

Authors:  Brent E Fitzwalter; Andrew Thorburn
Journal:  Nat Cell Biol       Date:  2017-08-31       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.